Management of regional lymph nodes in early-stage breast cancer

doi:10.16139/j.1007-9610.2022.05.006

Abstract

CLC Number:

R737.9

CAO Lu, ZHENG Siyue, CHEN Jiayi. Management of regional lymph nodes in early-stage breast cancer[J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 406-410.

References 29

[1]	Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249.
[2]	Whelan TJ, Olivotto IA, Parulekar WR, et al. Regional nodal irradiation in early-stage breast cancer[J]. N Engl J Med, 2015, 373(4):307-316.
[3]	Poortmans PM, Weltens C, Fortpied C, et al. Internal mammary and medial supraclavicular lymph node chain irradiation in stage Ⅰ-Ⅲ breast cancer(EORTC 22922/10925):15-year results of a randomised, phase 3 trial[J]. Lancet Oncol, 2020, 21(12):1602-1610.
[4]	Thorsen LB, Offersen BV, Danø H, et al. DBCG-IMN: a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer[J]. J Clin Oncol, 2016, 34(4):314-320.
[5]	Kim YB, Byun HK, Kim DY, et al. Effect of elective internal mammary node irradiation on disease-free survival in women with node-positive breast cancer: a randomized phase 3 clinical trial[J]. JAMA Oncol, 2022, 8(1):96-105.
[6]	Balic M, Thomssen C, Würstlein R, et al. St.Gallen/Vienna 2019: a brief summary of the consensus discussion on the optimal primary breast cancer treatment[J]. Breast Care, 2019, 14(2):103-110.
[7]	Zhang L, Zhou M, Liu Y, et al. Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy? an analysis based on RecurIndex assay[J]. Inter J Cancer, 2021, 149(10):1801-1808.
[8]	Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial[J]. Lancet Oncol, 2010, 11(10):927-933.
[9]	Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs. no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial[J]. JAMA, 2017, 318(10):918-926.
[10]	NCCN clinical practice guidelines in oncology-breast cancer(Version 1.2012)[DB/OL]. [2022-07-28].
[11]	Galimberti V, Cole Bf, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases(IBCSG 23-01):10-year follow-up of a randomised, controlled phase 3 trial[J]. Lancet Oncol, 2018, 19(10):1385-1393.
[12]	Solá M, Alberro JA, Fraile M, et al. Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000[J]. Ann Surg Oncol, 2013, 20(1):120-127.
[13]	Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial[J]. Lancet Oncol, 2014, 15(12):1303-1310.
[14]	Sávolt á, Péley G, Polgár C, et al. Eight-year follow up result of the OTOASOR trial: the Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase Ⅲ, non-inferiority trial[J]. Eur J Surg Oncol, 2017, 43(4):672-679.
[15]	Wang NN, Yang ZJ, Wang X, et al. A mathematical prediction model incorporating molecular subtype for risk of non-sentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients: a retrospective ana-lysis and nomogram development[J]. Breast Cancer, 2018, 25(6):629-638.
[16]	Jagsi R, Chadha M, Moni J, et al. Radiation field design in the ACOSOG Z0011 (Alliance) trial[J]. J Clin Oncol, 2014, 32(32):3600-3606.
[17]	Goyal A, Mann GB, Fallowfield L, et al. POSNOC—PO-sitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in wo-men with early-stage breast cancer who have metastases in one or two sentinel nodes[J]. BMJ Open, 2021, 11(12):e054365.
[18]	Gentilini O, Botteri E, Leonardi MC, et al. Ipsilateral axillary recurrence after breast conservative surgery: the protective effect of whole breast radiotherapy[J]. Radiother Oncol, 2017, 122(1):37-44.
[19]	Turashvili G, Wen HY. Multigene testing in breast cancer: what have we learned from the 21-gene recurrence score assay?[J]. Breast J, 2020, 26(6):1199-1207.
[20]	Reimer T, Stachs A, Nekljudova V, et al. Restricted axillary staging in clinically and sonographically node-negative early invasive breast cancer (c/iT1-2) in the context of breast conserving therapy: first results follow-ing commencement of the intergroup-sentinel-mamma (INSEMA) trial[J]. Geburtshilfe Frauenheilkd, 2017, 77(2):149-157.
[21]	Garda AE, Hunzeker AE, Michel AK, et al. Intensity modulated proton therapy for bilateral breast or chest wall and comprehensive nodal irradiation for synchronous bilateral breast cancer: initial clinical experience and dosimetric comparison[J]. Adv Radiat Oncol, 2022, 7(3):100901.
[22]	Jacobson G, Bunda-Randall N, Wen S, et al. Axillary lymph node coverage with 3-dimensional tangential field irradiation and correlation with heart and lung dose[J]. Adv Radiat Oncol, 2017, 2(4):630-635.
[23]	Ahrouch I, van Gestel D, Koshariuk O, et al. Unintended dose to the lower axilla in adjuvant radiotherapy for breast cancer: differences between tangential beam and VMAT[J]. Radiother Oncol, 2021, 164:282-288.
[24]	Hildebrandt G, Stachs A, Gerber B, et al. Central review of radiation therapy planning among patients with breast-conserving surgery: results from a quality assurance process integrated into the INSEMA trial[J]. Int J Radiat Oncol Biol Phys, 2020, 107(4):683-693.
[25]	Henke G, Knauer M, Ribi K, et al. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-Ⅲ trial[J]. Trials, 2018, 19(1):667.
[26]	Weber WP, Matrai Z, Hayoz S, et al. Tailored axillary surgery in patients with clinically node-positive breast cancer: pre-planned feasibility substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)[J]. Breast, 2021, 60:98-110.
[27]	Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study[J]. Lancet Oncol, 2013, 14(7):609-618.
[28]	Boughey JC. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071(Alliance) clinical trial[J]. JAMA, 2013, 310(14):1455-1461.
[29]	Gandhi A, Coles C, Makris A, et al. Axillary surgery following neoadjuvant chemotherapy-multidisciplinary guidance from the association of breast surgery, faculty of clinical oncology of the Royal College of Radiologists, UK Breast Cancer Group, National Coordinating Committee for Breast Pathology and British Society of Breast Radiology[J]. Clin Oncol, 2019, 31(9):664-668.

Management of regional lymph nodes in early-stage breast cancer

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 29

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHU Qiaoli, MIAO Yiming, CHEN Xiaosong. Prognostic analysis of breast-conserving surgery or mastectomy in patients with stage Ⅰ-Ⅲ triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 371-377.
[2]	YANG Yi, YANG Xingxia, JIN Sili, ZHANG Xu, ZHU Juanying, CHEN Xiaosong. Clinical application of preoperative MRI examination in breast-conserving surgery for ductal carcinoma in situ [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 378-382.
[3]	DONG Jun, CUI Fengming, LIU Jun. Effects of silencing Ki-67 gene on doxorubicin resistance of breast cancer MCF-7/DOX cells [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 254-259.
[4]	GAO Weiqi, ZHANG Xu, WANG Zheng, ZHU Yifei, HUANG Jiahui, HONG Jin, ZHU Siji, CHEN Xiaosong, HUANG Ou, HE Jianrong, CHEN Weiguo, LI Yafen, SHEN Kunwei, XU Hua, WU Jiayi. Safety analysis of immediate breast reconstruction with deep inferior epigastric perforator after neoadjuvant treatment [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 147-151.
[5]	ZHOU Wenbin, TANG Xinyu, WANG Shui. Application of local microwave ablation in treatment of breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 403-405.
[6]	XIE Yanyan, LU Qing, DU Zhenggui. Endoscopic and robotic breast surgery: present and future—the experience of West China Hospital [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 396-402.
[7]	CHEN Yiding, WU Shijie. Surgical treatment of hereditary breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 392-395.
[8]	WU Jiayi, LU Yujie, HE Jinguang, SHEN Kunwei, XU Hua. Post-mastectomy implant-based breast reconstruction [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 387-391.
[9]	CHEN Xiaosong, SHEN Kunwei, Ll Hongwei. Diagnosis and treatment in early operable breast cancer: current status and prospect [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 385-386.
[10]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 411-415.
[11]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 416-420.
[12]	YANG Cuiyan, WANG Haoyu, CHEN Xiaosong, SHEN Kunwei. Study on tumour suppressor gene TP53 mutation and prognosis in patients with triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 421-428.
[13]	PAN Ruixin, CHEN Xiaosong, SHEN Kunwei. Study on circulating tumor DNA and circulating tumor cell detecting minimal residual disease in breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 463-467.
[14]	ZHU Siyi, CHEN Xiaosong, SHEN Kunwei. Study on obesity associated with prognosis of early breast cancer and efficacy of adjuvant therapy [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 468-472.
[15]	WANG Jieqiang, MA Dekui. Study on trophoblast cell-surface antigen 2 gene and triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 473-477.